Michael Holinstat is a professor in the Department of Pharmacology and a fellow of the American Heart Association. He obtained a PhD at the University of Illinois at Chicago, Chicago in 2004. He serves as the inaugural Director of the Platelet Physiology and Pharmacology Platelet Core at the University of Michigan. Additionally, Dr. Holinstat serves on several national boards including the sub-committee on Hemostasis and Thrombosis at the American Society for Hematology and the Director for the NIH CTSI-funded T32 training grant in clinical research. Dr. Holinstat has received several national awards including the Kenneth M. Brinkhous Young Investigator Prize in Thrombosis from the Council on Arteriosclerosis, Thrombosis, and Vascular Biology in 2012 and the Young Investigator Award in Structure-Function from the Eicosanoid Research Foundation in 2013. Dr. Holinstat has received numerous patents from patent offices in the US, EU, and Japan for various therapeutic discoveries to treat cardiovascular disease. In addition to his NIH-funded research, Dr. Holinstat continues to translate his discoveries into potential clinical applications through collaborations with Veralox Therapeutics, Cereno Scientific, and Lexicon Pharmaceuticals.
Michael Holinstat is a professor in the Department of Pharmacology and a fellow of the American Heart Association. He obtained a PhD at the University of Illinois at Chicago, Chicago in 2004. He serves as the inaugural Director of the Platelet Physiology and Pharmacology Platelet Core at the University of Michigan. Additionally, Dr. Holinstat serves on several national boards including the sub-committee on Hemostasis and Thrombosis at the American Society for Hematology and the Director for the NIH CTSI-funded T32 training grant in clinical research. Dr. Holinstat has received several national awards including the Kenneth M. Brinkhous Young Investigator Prize in Thrombosis from the Council on Arteriosclerosis, Thrombosis, and Vascular Biology in 2012 and the Young Investigator Award in Structure-Function from the Eicosanoid Research Foundation in 2013. Dr. Holinstat has received numerous patents from patent offices in the US, EU, and Japan for various therapeutic discoveries to treat cardiovascular disease. In addition to his NIH-funded research, Dr. Holinstat continues to translate his discoveries into potential clinical applications through collaborations with Veralox Therapeutics, Cereno Scientific, and Lexicon Pharmaceuticals.